News & Articles

Three subject experts explain the difference between central lab and point-of-care testing and what this means for patients with chronic disease

Prof. Dirk Homann shares his research at the interface of infectious and autoimmune disease

Discover what it takes to set up an accredited COVID-19 testing laboratory and learn more about COVID-19 project delivery around the world

The artus® SARS-CoV-2 Prep&Amp UM cuts PCR processing times by two thirds

Explore how a partnership between a lead researcher in sexual health and a molecular diagnostics innovator helped to overcome the therapeutic hurdles that come with antibiotic resistance

Avacta provides recent updates on the performance of its antigen lateral flow tests with the Omicron variant

The partnership aims to distribute Nanotrap® Magnetic Virus Particles that provide rapid viral concentration directly from raw sewage.

Watch this on-demand webinar to find out how you can ensure product safety and quality of IVD products

The award comes after Avacta obtained regulatory approval for the Lateral Flow Test

The easy-to-use workflow can detect T-cell response early in the course of COVID-19 infection or following vaccination

Data shows that iota-carrageenan might be an effective virus blocker irrespective of present and possible future SARS-CoV-2 mutations

Learn how antibody researchers teamed up with a biologics manufacturer to develop novel diagnostic tests and treatments for viral infections

A study by experts at King's College London has found that symptoms of early COVID-19 are similar to vaccine side-effects

Find out how unbiased lab product reviews are changing the world of science - and why not get involved yourself?

Leading clinicians discuss the latest developments in point of care testing for cardiac disease, myocardial infarction, and blood gas analysis

Both vaccines are highly effective and either one is strongly recommended

Models future SARS-CoV-2 mutations and forecasts their ability to evade immune defenses developed by vaccines and antibody-based treatments

bioMérieux conducts in-depth analyses of its molecular tests on emerging variants of concern

the In silico analysis of lineage B.1.1.529 (Omicron) is applicable to the VIASURE range of products

Company testing three existing COVID-19 vaccine booster candidates against the Omicron variant

A true walk away ‘sample to answer’ molecular diagnostic system designed for high throughput testing, offering a time-efficient and seamless workflow for clinical laboratories

The assays have shown efficacy against the newest variants of concern

Testing positive on a COVID-19 PCR test has been shown to have a positive correlation to mental illness and sleep problems